An Improved Process for the Preparation of Dabigatran Etexilate Mesylate and Synthesis of its Impurities

The present invention describes the improved process for the preparation of dabigatran etexilate mesylate and impurities synthesis. TheSynthesis involves easily available commercial raw materials with Acylation from n-hexyl chloroformate makes to get desired DabigatranEtexilate from the methane sulfonic acid it is finally as a dabigatran etexilate mesylate salt with an effective yield. Catalyst free and pressure handled reactions are not performed. Dabigatran is an effective oral prodrug of the thrombin (Factor IIa) inhibitor it has been approved by FDA and is widely used to reduce the risk of stroke in patients with non-valvular atrial fibrillation.
Jar, Beaker, Lab, Liquid, Cup, Bottle, Tool, Medical

Comments

Popular posts from this blog

Synthesis Characterization and Evaluation of Novel Substituted Azole Derivatives

Separation and Identification of the Components of Acacia Sieberiana Stem Bark Plant Extract and Study its Safety as a Treatment Drug for Diarrhea

Reuse of Treated Wastewater of the City of Salé in Agriculture